• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

This week in optometry: June 5-June 9

Article

Catch up on what happened in optometry during the week of June 5-June 9.

Catch up with what Optometry Times®' shared this week:

Image Credit: © Fernando - stock.adobe.com

Adobe Stock/Fernando

Optometry news

A funny thing happened at the office: Part 2

Chris Wroten, OD

Who doesn’t love a good joke? One definition of funny is “strange or odd,” and we’ve all got our strange tales from the exam room. Here are a couple of mine and what I learned from them.

Read more...

Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses

Emily Kaiser, Assistant Managing Editor

Bausch + Lomb announced the United States launch of their Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. The lenses leverage Bausch + Lomb’s ProBalance Technology and their proprietary 3-Zone Progressive design to deliver all-day comfort and seamless transitions across near, intermediate, and distance vision in the hopes of meeting the dynamic vision needs of patients with presbyopia.1

Learn more...

Glaukos’ phase 3 confirmatory trial for Epioxa reaches pipeline enrollment milestone

Kassi Jackson, Editor

Glaukos has announced the completion of enrollment and randomization in its second phase 3 confirmatory pivotal trial for Epioxa (Epi-on), the company’s second-generation corneal cross-linking therapy for the treatment of keratoconus. Glaukos is expected to file a New Drug Application (NDA) with the US Food and Drug Administration (FDA) by the end of 2024.1

Continue reading...

Meet the LEO founding board: Dr Glenda Aleman Moheeputh

Glenda Aleman Moheeputh, OD; Kassi Jackson, Editor

Glenda Aleman Moheeputh, OD, president and CEO of OK Love Myopia Control Experts in Florida, sat down with Optometry Times®' editor Kassi Jackson to talk about her role on the founding board of Latinos en Optometry (LEO).

Founded by Diana Canto-Sims, OD, LEO has 5 goals:

  1. Increase the number of Latino students in optometry schools
  2. Provide resources and communication for Latinos in optometry
  3. Provide resources and communication for the eye care community who serve the Latino community
  4. Be a conduit between the Latino community and the eye care industry
  5. Provide CE to all optometry

The founding board of Latinos En Optometry includes Diana Canto-Sims, OD, CEO, Founder and Stylist of La Vida Eyewear and Co-Owner of Buena Vista Optical in Chicago, IL; Lawrence Chavez, Founder & CEO of EveryDay Contacts; Howard Purcell, OD, President and CEO of the New England College of Optometry; Hector Santiago, OD, PhD, Professor and Director of Research Activities at Inter American University of Puerto Rico School of Optometry; Glenda Aleman Moheeputh, OD, Founder and CEO of OK Love Myopia Control Experts; Karen Carrasquillo, OD, PhD, Senior Vice President Clinical and Professional Affairs at BostonSight; Diana Shechtman, OD, Fellow at the American Academy of Optometry and Optometric Retinal Society; and Lina Arango, OD, who currently works as an Independent Doctor with LTA Vision corporation.

Get to know Dr. Aleman...

Into the periphery with lattice retinal degeneration

Leo P. Semes, OD, FAAO

Lattice retinal degeneration is the most significant peripheral retinal change associated with retinal detachment. Generally, it is a stable condition without symptoms unless the complication of a retinal tear develops, which can lead to retinal detachment. There are a number of presentations among patients, who can be of a young age and have almost any refractive correction.

Read the case reports and discussion...

Joey Gase named ambassador by National Keratoconus Foundation

Optometry Times Staff Reports; Kassi Jackson, Editor

The National Keratoconus Foundation (NKCF) has named NASCAR driver Joey Gase as ambassador.

Gase, from Cedar Rapids, Iowa, discovered his lifelong passion when he won the first of many Go-Kart races at age 8. By 18, Joey had been signed as a professional driver and was competing in the NASCAR Nationwide Series. Today, Joey is driver and co-owner of Emerling-Gase Motorsports and has competed in more than 350 NASCAR events.

The NKCF is the world’s oldest and largest organization dedicated to increasing awareness of keratoconus (KC), a bilateral eye disease characterized by progressive thinning and bulging of the cornea which results in vision impairment.

Read on...

AOA 2023: Championing the future of optometry

Lynda Charters

The American Optometric Association (AOA) Optometry’s Meeting will convene its 126th annual congress from Wednesday, June 21 to Saturday, June 24, 2023, in Washington, DC, at the Walter E. Washington Convention Center.

The meeting provides opportunity for optometric continuing education and professional development, with networking and business opportunities among colleagues, industry professionals, and the profession's leaders.

Learn more...

The role of comanagement in specialized scleral contact lens fitting

Thomas A. Wong, OD, FNAP; Marin Nagelberg, BS; Travis Pfeifer, BA; Sharon P. Keh OD, FAAO

Scleral contact lenses are becoming more popular because of their unique design. Unlike other contact lenses, scleral lenses vault over the cornea and rest on the conjunctiva overlying the sclera. This makes them more comfortable than other types of gas permeable contact lenses, and allows them to be used to correct a wider range of vision problems.

For patients who wear scleral lenses for therapeutic purposes, it is important to manage their relevant corneal disease, ocular surface disease, and refractive error.1 For these patients, comanagement of their underlying ocular and systemic conditions is often the key to success.

Read on...

Local vision clinic provides Orlando community members with free eye health care

Kassi Jackson, Editor

The second annual local vision clinic hosted by the North America affiliate of the OneSight EssilorLuxottica Foundation in partnership with Transitions was held last month in Orlando. The clinic aims to address the unmet needs of 83 local Pathlight HOME clients who may have otherwise lacked access to eye exams and glasses.

After last year’s clinic, seeing the positive role the comprehensive eye exams played in Orlando, Transitions and Transitions Optical’s Diversity Advisory Board wanted to provide the opportunity for the second year in a row.

More here...

Related Videos
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Marjorie Rah, OD, PhD, FAAO
Selina McGee, OD, FAAO
Kelsey Roelofs, MD, details the best methods to identify thyroid eye disease at CIME 2024
Melissa Tawa, OD, FAAO
Deborah Ristvedt, DO, details CIME 2024 presentation on glaucoma management
David A. Berntsen, OD, PhD, FAAO, outlines his presentation on the BLINK 2 study presented at the 2024 ARVO meeting
© 2024 MJH Life Sciences

All rights reserved.